Petitioner Urges Board To Cancel Patented DNA Sequencing Method
ALEXANDRIA, Va. — In an April 8 petition for inter partes review (IPR) filed with the Patent Trial and Appeal Board, a cancer diagnostics company takes aim at a University of...To view the full article, register now.
Already a subscriber? Click here to view full article